GlassScriptPhysician profile
Jeffrey B Marvel
NPI 1740285063
$20,620.19
in general payments reported to CMS, 2019-2025
12 companies · $270 in 2025
The $270 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16K · 2020: $69.12 · 2021: $988 · 2022: $1,088 · 2023: $1,314 · 2024: $717 · 2025: $270.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,603 · Travel and Lodging: $684 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $14.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,602.67 |
| Travel and Lodging | $683.51 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $14.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $16,789.41 | 2019-2022 | |
| Stryker Corporation | $1,545.46 | 2019-2024 | Scopis Ent, Clarifix Cryotherapy Device, Xpress Ent Dilation System |
| Merz North America, INC. | $626.61 | 2021-2023 | Xeomin |
| Inspire Medical Systems, INC. | $493.15 | 2021-2025 | Inspire |
| Abbvie INC. | $429.74 | 2023-2024 | |
| Aerin Medical INC. | $222.57 | 2023-2024 | |
| Intersect Ent, INC. | $170.53 | 2021 | |
| Smith+Nephew, INC. | $143.52 | 2024 | Halo, Na, Goflo Pump |
| Jazz Pharmaceuticals INC. | $71.45 | 2022 | |
| Glaxosmithkline, LLC. | $50.41 | 2023-2024 | Nucala |
| Acclarent, INC | $45.68 | 2023 | Trudi Nav Cable |
| Galderma Laboratories, L.P. | $31.66 | 2020-2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Marvel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.